Clinical Performance of Four Restorative Materials in Primary Molars
NCT: NCT07504393 · NOT_YET_RECRUITING
Brief Summary
This randomized clinical trial aims to compare the clinical and radiographic performance of four direct restorative materials used for restoring carious primary molars in children. Eligible children aged 4-8 years with posterior primary molars requiring direct restoration will be randomly allocated (1:1:1:1) to receive one of the following materials: an alkasite restorative material (Cention N), a self-cure bulk-fill resin composite (Stela; SDI), a conventional light-cured nanohybrid resin composite (Beautifil II), or a resin-modified glass ionomer cement (Riva Light Cure). Restorations will be evaluated using the Fédération Dentaire Internationale (FDI) World Dental Federation criteria. Postoperative sensitivity will be assessed at 48 hours using a 0-10 visual analogue scale (VAS). Clinical and radiographic follow-up assessments will be conducted at baseline and at scheduled recall visits
Frequently Asked Questions
What is Clinical Performance of Four Restorative Materials in Primary Molars?
Clinical Performance of Four Restorative Materials in Primary Molars is a clinical trial registered under NCT07504393. Current status: NOT_YET_RECRUITING.
What is the status of NCT07504393?
The current status of NCT07504393 (Clinical Performance of Four Restorative Materials in Primary Molars) is: NOT_YET_RECRUITING.
When did Clinical Performance of Four Restorative Materials in Primary Molars start?
Clinical Performance of Four Restorative Materials in Primary Molars started on 2026-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.